Even though the TMZ cohort is at a disadvantage, especially because of the comparably large tumor volumes, the inferiority as compared to the W&S cohort in terms of survival despite identical initial PFS was clear and highly significant.
← all excerpts
Limited efficacy of temozolomide alone for astrocytoma, IDH-mutant, CNS WHO grades 2 or 3.
1
—
—